125 related articles for article (PubMed ID: 10845191)
1. Differentiation of responses to allergenic and irritant compounds in mouse popliteal lymph node assay.
Suda A; Iwaki Y; Kimura M
J Toxicol Sci; 2000 May; 25(2):131-6. PubMed ID: 10845191
[TBL] [Abstract][Full Text] [Related]
2. Local lymph node assay: differentiating allergic and irritant responses using flow cytometry.
Gerberick GF; Cruse LW; Ryan CA
Methods; 1999 Sep; 19(1):48-55. PubMed ID: 10525437
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of allergenic potential of low-molecular compounds by mouse popliteal lymph node assay.
Aida T; Kimura T; Ishikawa N; Shinkai K
J Toxicol Sci; 1998 Dec; 23(5):425-32. PubMed ID: 9922946
[TBL] [Abstract][Full Text] [Related]
4. BALB/c mice orally pretreated with diclofenac have augmented and accelerated PLNA responses to diclofenac.
Gutting BW; Updyke LW; Amacher DE
Toxicology; 2002 Apr; 172(3):217-30. PubMed ID: 11893420
[TBL] [Abstract][Full Text] [Related]
5. Mouse popliteal lymph node assay for assessment of allergic and autoimmunity-inducing potentials of low-molecular-weight drugs.
Shinkai K; Nakamura K; Tsutsui N; Kuninishi Y; Iwaki Y; Nishida H; Suzuki R; Vohr HW; Takahashi M; Takahashi K; Kamimura Y; Maki E
J Toxicol Sci; 1999 May; 24(2):95-102. PubMed ID: 10349611
[TBL] [Abstract][Full Text] [Related]
6. Use of a B cell marker (B220) to discriminate between allergens and irritants in the local lymph node assay.
Gerberick GF; Cruse LW; Ryan CA; Hulette BC; Chaney JG; Skinner RA; Dearman RJ; Kimber I
Toxicol Sci; 2002 Aug; 68(2):420-8. PubMed ID: 12151637
[TBL] [Abstract][Full Text] [Related]
7. Diclofenac activates T cells in the direct popliteal lymph node assay and selectively induces IgG(1) and IgE against co-injected TNP-OVA.
Gutting BW; Updyke LW; Amacher DE
Toxicol Lett; 2002 May; 131(3):167-80. PubMed ID: 11992736
[TBL] [Abstract][Full Text] [Related]
8. Oxazolone and diclofenac-induced popliteal lymph node assay reactions are attenuated in mice orally pretreated with the respective compound: potential role for the induction of regulatory mechanisms following enteric administration.
Gutting BW; Bouzahzah F; Kong PL; Updyke LW; Amacher DE; Craft J
Toxicol Appl Pharmacol; 2003 Jun; 189(2):120-33. PubMed ID: 12781630
[TBL] [Abstract][Full Text] [Related]
9. Utilization of the ex vivo LLNA: BrdU-ELISA to distinguish the sensitizers from irritants in respect of 3 end points-lymphocyte proliferation, ear swelling, and cytokine profiles.
Arancioglu S; Ulker OC; Karakaya A
Int J Toxicol; 2015; 34(1):24-30. PubMed ID: 25563296
[TBL] [Abstract][Full Text] [Related]
10. Immunopathological signs in mice treated with mercury compounds--I. Identification by the popliteal lymph node assay of responder and nonresponder strains.
Stiller-Winkler R; Radaszkiewicz T; Gleichmann E
Int J Immunopharmacol; 1988; 10(4):475-84. PubMed ID: 3262595
[TBL] [Abstract][Full Text] [Related]
11. Investigating the TNP-OVA and direct popliteal lymph node assays for the detection of immunostimulation by drugs associated with anaphylaxis in humans.
Gutting BW; Updyke LW; Amacher DE
J Appl Toxicol; 2002; 22(3):177-83. PubMed ID: 12015798
[TBL] [Abstract][Full Text] [Related]
12. Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in the popliteal lymph node assay. II. Comparison with acute graft-vs-host reaction in H-2 incompatible F1 mouse hybrids.
Krzystyniak K; Panaye G; Descotes J; Revillard JP
Immunopharmacol Immunotoxicol; 1992; 14(4):865-82. PubMed ID: 1363474
[TBL] [Abstract][Full Text] [Related]
13. Immune modulation by cadmium and lead in the acute reporter antigen-popliteal lymph node assay.
Carey JB; Allshire A; van Pelt FN
Toxicol Sci; 2006 May; 91(1):113-22. PubMed ID: 16495351
[TBL] [Abstract][Full Text] [Related]
14. Popliteal lymph node assay: facts and perspectives.
Ravel G; Descotes J
J Appl Toxicol; 2005; 25(6):451-8. PubMed ID: 15986413
[TBL] [Abstract][Full Text] [Related]
15. Local popliteal lymph node reactions to hexachlorobenzene and pentachlorobenzene: comparison with systemic effects.
Schielen P; Van Der Pijl A; Bleumink R; Pieters RH; Seinen W
Immunopharmacology; 1996 Mar; 31(2-3):171-81. PubMed ID: 8861743
[TBL] [Abstract][Full Text] [Related]
16. A nonradioisotopic endpoint for measurement of lymph node cell proliferation in a murine allergic contact dermatitis model, using bromodeoxyuridine immunohistochemistry.
Lee JK; Park JH; Park SH; Kim HS; Oh HY
J Pharmacol Toxicol Methods; 2002; 48(1):53-61. PubMed ID: 12750042
[TBL] [Abstract][Full Text] [Related]
17. Development of a flow cytometry assay for the identification and differentiation of chemicals with the potential to elicit irritation, IgE-mediated, or T cell-mediated hypersensitivity responses.
Manetz TS; Meade BJ
Toxicol Sci; 1999 Apr; 48(2):206-17. PubMed ID: 10353312
[TBL] [Abstract][Full Text] [Related]
18. Intralaboratory validation of alternative endpoints in the murine local lymph node assay for the identification of contact allergic potential: primary ear skin irritation and ear-draining lymph node hyperplasia induced by topical chemicals.
Ulrich P; Streich J; Suter W
Arch Toxicol; 2001 Feb; 74(12):733-44. PubMed ID: 11305775
[TBL] [Abstract][Full Text] [Related]
19. Selective modulation of B-cell activation markers CD86 and I-Ak on murine draining lymph node cells following allergen or irritant treatment.
Gerberick GF; Cruse LW; Miller CM; Ridder GM
Toxicol Appl Pharmacol; 1999 Sep; 159(2):142-51. PubMed ID: 10495778
[TBL] [Abstract][Full Text] [Related]
20. A method for measuring mouse respiratory allergic reaction to low-dose chemical exposure to allergens: an environmental chemical of uncertain allergenicity, a typical contact allergen and a non-sensitizing irritant.
Fukuyama T; Tajima Y; Ueda H; Hayashi K; Shutoh Y; Harada T; Kosaka T
Toxicol Lett; 2010 May; 195(1):35-43. PubMed ID: 20219652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
